you are here: HomeNewsRemdesivir
remdesivir
Jump to
77 Results Found
  • Chemotherapy drug outperforms remdesivir against coronavirus in lab experiments: Study Jan 03, 2021 03:03 PM IST

    Chemotherapy drug outperforms remdesivir against coronavirus in lab experiments: Study

    The research, published in the journal PLOS Computational Biology, combined multiple computational techniques that simulate drug-virus interactions from different, complimentary perspectives.

  • Maharashtra government fixes price of Remdesivir injection at Rs 2,360 apiece Dec 04, 2020 07:17 PM IST

    Maharashtra government fixes price of Remdesivir injection at Rs 2,360 apiece

    The government has also put together a list of 59 pharmaceutical outlets where it can be purchased, covering all the major cities, towns and districts, said Dr Pradeep Vyas, principal secretary, public health and family welfare.

  • Indian demand for COVID-19 drug Remdesivir rising sharply: Cipla Nov 09, 2020 02:51 PM IST

    Indian demand for COVID-19 drug Remdesivir rising sharply: Cipla

    Remdesivir was developed by US drugmaker Gilead Sciences Inc , which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of the treatment. Cipla is among several firms licensed to make and sell generic versions in developing nations.

  • WHO-led COVID-19 drug scheme doubles down on antibodies, steroids and shuns remdesivir Nov 05, 2020 06:55 PM IST

    WHO-led COVID-19 drug scheme doubles down on antibodies, steroids and shuns remdesivir

    The WHO draft document, seen by Reuters and dated October 30, says the priorities are to secure monoclonal antibodies in a tight market and to boost purchases and distribution of cheap steroid dexamethasone, of which it has already booked nearly 3 million courses of treatment for poorer countries.

  • COVID-19 treatment | DGCI rejects Dr Reddy’s application for full market authorisation for remdesivir: Report Nov 03, 2020 09:28 AM IST

    COVID-19 treatment | DGCI rejects Dr Reddy’s application for full market authorisation for remdesivir: Report

    Dr Reddy’s proposal comes after the USFDA granted remdesivir full regulatory status – making it the first COVID-19 drug to receive full approval

  • Dr Reddy’s: Better US prospects to sustain valuations Oct 29, 2020 03:52 PM IST

    Dr Reddy’s: Better US prospects to sustain valuations

    Dr Reddy's US growth prospects have improved after its recent settlement with Bristol Myers Squibb to launch an oncology drug

  • SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19 Oct 29, 2020 02:56 PM IST

    SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19

    Advocate M L Sharma petitioner in-person referred to the bench, also comprising Justices A S Bopanna and V Ramasubramanian, the World Health Organization (WHO) report of October 15 and said that nowhere these medicines are designated officially as medicines for coronavirus.

  • WHO says it will have advice on remdesivir in 3-4 weeks Oct 23, 2020 10:10 PM IST

    WHO says it will have advice on remdesivir in 3-4 weeks

    "We would anticipate that the guidelines will be available within three to four weeks," Janet Diaz, the WHO's top official for clinical care responses, told a news conference.

  • COVID-19 treatment: Demand for remdesivir largely unaffected; doctors continue use due to fewer options Oct 20, 2020 01:03 PM IST

    COVID-19 treatment: Demand for remdesivir largely unaffected; doctors continue use due to fewer options

    Health Ministry is yet to revise the existing protocol for COVID-19 treatment, which advises the use of remdesivir as an investigational therapy for treatment.

  • Government to review COVID-19 treatment protocol after WHO trial finds remdesivir ineffective Oct 17, 2020 10:23 AM IST

    Government to review COVID-19 treatment protocol after WHO trial finds remdesivir ineffective

    The results of the WHO's solidarity trial found that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon had little or no effect on 28-day mortality.

  • Cadila: a formidable play in Covid times and beyond Sep 25, 2020 09:39 AM IST

    Cadila: a formidable play in Covid times and beyond

    Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.

  • Remdesivir batch withdrawn due to inferior quality: Maharashtra Health Minister Rajesh Tope Sep 23, 2020 05:50 PM IST

    Remdesivir batch withdrawn due to inferior quality: Maharashtra Health Minister Rajesh Tope

    Rajesh Tope told reporters that the move caused a short-term shortage of the drug in the state.

  • COVID-19 pandemic | Shortage of remdesivir resurfaces in Mumbai: Report Sep 20, 2020 09:53 AM IST

    COVID-19 pandemic | Shortage of remdesivir resurfaces in Mumbai: Report

    Spike in COVID-19 cases after the Ganpati festival, large-scale exports and suppliers targeting other states where they are getting a higher price may have led to the shortage of remdesivir.

  • US hospitals turn down remdesivir, limit use to sickest COVID-19 patients Sep 12, 2020 11:51 AM IST

    US hospitals turn down remdesivir, limit use to sickest COVID-19 patients

    Some hospitals said they are still buying the Gilead Sciences medicine to build inventory in case the pandemic accelerates over the winter. But they said current supplies are adequate, in part because they are limiting use to severely ill patients.

  • Prospects for US business and leadership in respiratory therapies make Cipla attractive Aug 10, 2020 08:15 AM IST

    Prospects for US business and leadership in respiratory therapies make Cipla attractive

    Cipla's US revenues clocked a sequential improvement to about $135 million, backed by a ramp-up in the generic version of gProventil HFA

  • Jubilant Life Sciences presents 1,000 vials of Remdesivir to Uttar Pradesh CM Yogi Adityanath Aug 08, 2020 07:35 PM IST

    Jubilant Life Sciences presents 1,000 vials of Remdesivir to Uttar Pradesh CM Yogi Adityanath

    The drug is being made available to over 1,000 hospitals providing COVID-19 treatment in India through the company's distribution network, Jubilant Life Sciences said in a statement.

  • Pfizer signs deal to manufacture and supply Gilead's remdesivir for COVID-19 treatment Aug 07, 2020 06:07 PM IST

    Pfizer signs deal to manufacture and supply Gilead's remdesivir for COVID-19 treatment

    The US drugmaker would provide contract manufacturing services at its facility in Kansas to produce the drug.

  • European Union executive signs remdesivir deal with Gilead Jul 29, 2020 04:10 PM IST

    European Union executive signs remdesivir deal with Gilead

    Spinant said the contract was worth 63 million euros ($73.99 million) and would provide treatment to 30,000 patients with severe COVID-19 symptoms.

  • COVID-19 treatment | Mylan launches generic version of Remdesivir in India Jul 20, 2020 02:36 PM IST

    COVID-19 treatment | Mylan launches generic version of Remdesivir in India

    The drug is approved for treatment of suspected or laboratory confirmed incidences of COVID-19 in adults and children hospitalised with severe presentations of the disease, Mylan said in a statement

  • Coronavirus pandemic | Maharashtra govt procures 60,000 vials of Remdesivir for COVID-19 patients Jul 19, 2020 05:49 PM IST

    Coronavirus pandemic | Maharashtra govt procures 60,000 vials of Remdesivir for COVID-19 patients

    The Directorate of Medical Education and Research placed the order for Remdesivir at Rs 3,392.48 per vial, while Tocilizumab was acquired at Rs 30,870 per vial, and Favipiravir at Rs 1999.20 per strip.

  • Seven held for selling Remdesivir injections at higher cost Jul 19, 2020 04:51 PM IST

    Seven held for selling Remdesivir injections at higher cost

    The accused were selling a vial of the injection for Rs 30,000, much higher than the MRP of Rs 5,400, he said.

  • COVID-19 India update | Govt asks Remdesivir manufacturers to increase production as complaints of black marketing rise Jul 14, 2020 12:09 PM IST

    COVID-19 India update | Govt asks Remdesivir manufacturers to increase production as complaints of black marketing rise

    There have reports that remdesivir is being sold at exorbitant prices in the black market

  • One in three South Korean COVID-19 patients improved with remdesivir Jul 13, 2020 10:51 AM IST

    One in three South Korean COVID-19 patients improved with remdesivir

    Remdesivir has been at the forefront of the global battle against COVID-19 after the intravenously administered medicine helped shorten hospital recovery times in a US clinical trial.

  • Coronavirus pandemic | Aadhaar card, COVID-19 test results mandatory to buy remdisivir in Maharashtra Jul 12, 2020 06:40 PM IST

    Coronavirus pandemic | Aadhaar card, COVID-19 test results mandatory to buy remdisivir in Maharashtra

    Only COVID-19 positive patients with doctor’s prescription, Aadhaar card, and a phone number will be allowed to buy coronavirus treatment drugs remdisivir and tocilizumab in Maharashtra.

  • Remdesivir black marketing | Mumbai drug store owner arrested for selling COVID-19 medicine at Rs 20,000 per vial Jul 11, 2020 07:14 PM IST

    Remdesivir black marketing | Mumbai drug store owner arrested for selling COVID-19 medicine at Rs 20,000 per vial

    The police decoy recovered four vials of remdisivir – which are currently in high demand -- from the medicine shop located in Mira Road, which the accused had reportedly sourced from a hospital.

Sections